Abstract:Bohan Li Jie Zhao Qian Zhao Dongjin Wu Cheng Zhang Kun Zhao Yang Song Chunzheng Gao 1Health Management Center, The Second Hospital of Shandong University, Shandong 250033, People’s Republic of China; 2Department of Spine Surgery, The Second Hospital of Shandong University, Shandong 250033, People’s Republic of China; 3Jinan Central Hospital, The Affiliated Hospital of Shandong University, Shandong 250013, People’s Republic of China Purpose: Dysregulation of microRNA-618 (miR-618) has been observed in multiple types of human cancer. However, whether miR-618 is implicated in osteosarcoma (OS) initiation and progression is still unclear. Hence, we measured the expression of miR-618 in OS tissues and cell lines. In addition, the roles of miR-618 and the mechanisms underlying its activities in OS cells were examined. Methods: The expression status of miR-618 in OS was analyzed by reverse-transcription quantitative PCR. The regulatory roles of miR-618 overexpression in OS were explored by the Cell Counting Kit-8 assay, flow-cytometric analysis, Transwell cell migration and invasion assays, and a tumor xenograft experiment. Results: The results revealed that the expression of miR-618 was notably lower in OS tissues and cell lines, and that the low miR-618 expression significantly correlated with the clinical stage and distant metastasis among patients with OS. Exogenous miR-618 expression significantly suppressed OS cell proliferation, migration, and invasion and induced apoptosis in vitro as well as slowed tumor growth in vivo. Mechanism investigation indicated that metadherin (MTDH) is a direct target gene of miR-618 in OS cells. A knockdown of MTDH mimicked the tumor-suppressive effects of miR-618 upregulation on OS cells. Notably, resumption of MTDH expression attenuated the miR-618–mediated reduction in OS cell growth and metastasis in vitro. In addition, miR-618 overexpression reduced the PTEN–AKT pathway output in OS cells both in vitro and in vivo through downregulation of MTDH. Conclusion: To the best of our knowledge, this is the first study to show that miR-618 exerts crucial tumor-suppressive actions in OS pathogenesis by directly targeting MTDH mRNA and reducing PTEN–AKT pathway output. These results will help to elucidate the functions of miR-618 in OS and suggest that this miRNA may be investigated as a therapeutic target in this disease.

Mediator of RNA Polymerase II Transcription Subunit 19 Promotes Osteosarcoma Growth and Metastasis and Associates with Prognosis

Zinc finger Asp-His-His-Cys palmitoyl -acyltransferase 19 accelerates tumor progression through wnt/β-catenin pathway and is upregulated by miR-940 in osteosarcoma

Knockdown Of Med19 By Lentivirus-Mediated Shrna In Human Osteosarcoma Cells Inhibits Cell Proliferation By Inducing Cell Cycle Arrest In The G(0)/G(1) Phase

Research on Function of Med19 Gene Expression in Saos2 Cell's Proliferation

Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Siglec-15 Promotes Tumor Progression in Osteosarcoma via DUSP1/MAPK Pathway

Knockdown of mediator complex subunit 19 inhibits the growth of ovarian cancer.

MED19 Promotes Proliferation and Tumorigenesis of Lung Cancer

MicroRNA-876-5p Inhibits Cell Proliferation, Migration and Invasion by Targeting C-Met in Osteosarcoma.

Ott_a_219440 9795..9807

Mediator Complex Subunit 19 Promotes the Development of Hepatocellular Carcinoma by Regulating the AKT/mTOR Signaling Pathway

Indoleamine 2,3-dioxygenase 1 promotes osteosarcoma progression by regulating tumor-derived exosomal miRNA hsa-miR-23a-3p

Mir-216A Inhibits Osteosarcoma Cell Proliferation, Invasion and Metastasis by Targeting CDK14.

HIF-1α-mediated augmentation of miRNA-18b-5p facilitates proliferation and metastasis in osteosarcoma through attenuation PHF2

miR-19a-mediated downregulation of RhoB inhibits the dephosphorylation of AKT1 and induces osteosarcoma cell metastasis.

MicroRNA-618 Directly Targets Metadherin Mrna to Suppress the Malignant Phenotype of Osteosarcoma Cells by Reducing PTEN-AKT Pathway Output

Mir-3195 Suppresses the Malignant Progression of Osteosarcoma Cells Via Targeting SOX4.

Long Noncoding RNA CCDC144NL-AS1 Promotes the Oncogenicity of Osteosarcoma by Acting as a Molecular Sponge for microRNA-490-3p and Thereby Increasing HMGA2 Expression

Histone demethylase KDM5A promotes tumorigenesis of osteosarcoma tumor

Knockdown of long non-coding RNA HOXD-AS1 inhibits the progression of osteosarcoma.

Microrna-20a Promotes the Proliferation and Cell Cycle of Human Osteosarcoma Cells by Suppressing Early Growth Response 2 Expression